Krystal Biotech, Inc. (KRYS)
303.49
-2.19
(-0.72%)
USD |
NASDAQ |
Nov 13, 10:38
Krystal Biotech Profit Margin (Quarterly) : 49.53% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 49.53% |
| June 30, 2026 | 45.94% |
| March 31, 2026 | 48.07% |
| December 31, 2025 | 47.99% |
| September 30, 2025 | 81.15% |
| June 30, 2025 | 39.91% |
| Date | Value |
|---|---|
| March 31, 2025 | 40.52% |
| December 31, 2024 | 49.90% |
| September 30, 2024 | 32.42% |
| June 30, 2024 | 22.15% |
| March 31, 2024 | 2.06% |
| December 31, 2023 | 20.62% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -- |
| Ionis Pharmaceuticals, Inc. | -45.31% |
| Ultragenyx Pharmaceutical, Inc. | -68.21% |
| BridgeBio Pharma, Inc. | -17.13% |
| Cytokinetics, Inc. | -399.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.51% |
| Return on Assets | 15.95% |
| Return on Invested Capital | 17.39% |
| Gross Profit Margin (Quarterly) | 92.91% |
| Operating Margin (Quarterly) | 55.87% |
| Return on Net Operating Assets | 65.23% |